Accardi Mario Alberto 4
4 · Centessa Pharmaceuticals plc · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Accardi Mario Alberto
DirectorChief Executive Officer
Transactions
- Sale
Ordinary Shares
2025-07-29$15.23/sh−8,322$126,751→ 208,163 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.105 to $15.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.